QPX2015 / Shionogi - LARVOL DELTA

Phase 1 Oral QPX7831 Alone (SAD, MAD) and Combined With QPX2015, Including Effect of Food, in Healthy Adults (clinicaltrials.gov) - P1; N=136; Not yet recruiting; Sponsor: Qpex Biopharma, Inc.

Clinical • Combination therapy • New P1 trial • Infectious Disease

Phase 1 Study of Oral QPX2015 in Healthy Adult Subjects (clinicaltrials.gov) - P1; N=40; Completed; Sponsor: Qpex Biopharma, Inc.; Recruiting ➔ Completed; Trial completion date: Feb 2020 ➔ Oct 2019; Trial primary completion date: Feb 2020 ➔ Oct 2019

Clinical • Trial completion • Trial completion date • Trial primary completion date